Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $90.64 USD
Change Today +1.10 / 1.23%
Volume 5.1K
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

mesa laboratories inc (MLAB) Snapshot

Open
$90.01
Previous Close
$89.54
Day High
$90.95
Day Low
$89.71
52 Week High
06/16/15 - $92.80
52 Week Low
09/23/14 - $54.60
Market Cap
324.2M
Average Volume 10 Days
5.5K
EPS TTM
$2.62
Shares Outstanding
3.6M
EX-Date
05/27/15
P/E TM
34.6x
Dividend
$0.64
Dividend Yield
0.70%
Current Stock Chart for MESA LABORATORIES INC (MLAB)

Related News

No related news articles were found.

mesa laboratories inc (MLAB) Related Businessweek News

No Related Businessweek News Found

mesa laboratories inc (MLAB) Details

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The Instruments segment offers data loggers, a precision instrument that are used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the proper calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment, which are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring for various organizations; and torque testing systems used for the packaging industry. Its products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries. The Biological Indicators segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide, and radiation in the hospital, dental, medical device, and pharmaceutical industries. The Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and various other laboratory and industrial environments. The company markets its products through distributors in the United States, Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

276 Employees
Last Reported Date: 06/3/15
Founded in 1982

mesa laboratories inc (MLAB) Top Compensated Officers

Chief Executive Officer, President, Treasurer...
Total Annual Compensation: $316.5K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $214.3K
Chief Sales & Marketing Officer and Executive...
Total Annual Compensation: $212.7K
Senior Vice President of Operations
Total Annual Compensation: $160.0K
Senior Vice President of Operations
Total Annual Compensation: $160.0K
Compensation as of Fiscal Year 2015.

mesa laboratories inc (MLAB) Key Developments

Mesa Laboratories Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Mesa Laboratories Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company's revenues increased 18% to $18,560,000 as compared to $15,714,000 for the same quarter last year. Operating income for the quarter increased 23% to $4,202,000 as compared to $3,421,000 for the same quarter last year. Net income for the quarter decreased 35% to $2,239,000 or $0.61 per diluted share of common stock as compared to $3,462,000 or $0.95 per diluted share of common stock for the same quarter last year. On a non-GAAP basis, adjusted net income for the quarter decreased 30% to $2,930,000 or $0.80 per diluted share of common stock as compared to $4,188,000 or $1.15 per diluted share of common stock for the same quarter last year. Earnings before income taxes were $3,999,000 compared with $4,423,000 a year ago. For the year, the company's revenues increased 35% to $71,330,000 as compared to $52,724,000 last year. Operating income for the year increased 35% to $15,864,000 as compared to $11,785,000 last year. Net income for the year increased 6% to $9,583,000 or $2.63 per diluted share of common stock as compared to $9,000,000 or $2.49 per diluted share of common stock last year. Net income for the year ended March 31, 2015 was impacted by an unusual item consisting of $460,000 (before tax) of expenses associated with uncollected sales tax liabilities. Adjusted net income for the year increased 13% to $12,502,000 or $3.43 per diluted share of common stock as compared to $11,046,000 or $3.06 per diluted share of common stock last year. While Mesa's adjusted net income grew 13% for the year, compared to last year, adjusted net income for both the year and especially for the quarter were negatively impacted by a large swing in the effective tax rate and the one-time gain. Earnings before income taxes were $15,347,000 compared with $13,103,000 a year ago.

Mesa Laboratories Mulls Acquisitions

Mesa Laboratories Inc. (NasdaqGS:MLAB) is seeking acquisitions. John J. Sullivan, President and Chief Executive Officer, said, "As always, we will continue to focus on profitable growth based on expanding our distribution channels, introducing new products to our markets and seeking our additional business acquisition."

Mesa Laboratories Inc. Announces Board Changes

Effective April 8, 2015, Luke R. Schmieder retired as a director and the Chairman of the board of directors of Mesa Laboratories Inc. Mr. Schmieder served as a director and Chairman of the board of directors of the company since March 1982 and as the company's Chief Executive Officer and Treasurer from its inception in March 1982 through March 2009. The board of directors, upon the recommendation of the Nominating and Governance Committee, appointed John Schmieder to fill the remaining term of the director vacancy created by Luke R. Schmieder's retirement. In addition, the board of directors, upon the recommendation of the Nominating and Governance Committee, appointed H. Stuart Campbell, a current member of the board of directors since 1983, as the new Chairman of the Board of Directors. Both the appointment of John Schmieder as a director and the appointment of H. Stuart Campbell as the Chairman of the board of directors were effective April 8, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLAB:US $90.64 USD +1.10

MLAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $155.38 USD -0.27
Amphenol Corp $56.99 USD -0.46
Danaher Corp $86.80 USD +0.46
STERIS Corp $64.54 USD -0.12
Thermo Fisher Scientific Inc $130.95 USD +0.13
View Industry Companies
 

Industry Analysis

MLAB

Industry Average

Valuation MLAB Industry Range
Price/Earnings 33.9x
Price/Sales 4.4x
Price/Book 4.3x
Price/Cash Flow 33.2x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MESA LABORATORIES INC, please visit www.mesalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.